What is Technivie?
Technivie contains the antiviral medications ombitasvir, paritaprevir and ritonavir. These drugs work by preventing hepatitis C virus (HCV) from multiplying in the body. Technivie is used to treat genotype 4 chronic hepatitis C in adults without cirrhosis.
Who Makes it?
Technivie is manufactured by AbbVie, and was approved by the U.S. Food & Drug Administration (FDA) on July 24, 2015.
What is the Dosing?
The recommended dose of Technivie is 2 tablets taken orally once daily (in the morning). Technivie should be taken with a meal without regard to fat or calorie content [see Package Insert (PDF)].
How Much Does it Cost?
A 12-week regimen of Technivie costs nearly $77,000 before copay assistance. Ask your doctor about patient assistance programs.
What’s the Problem?
Technivie has been linked to an increased risk for serious liver disease which could require a liver transplant or even cause death, according to an FDA warning issued on October 22, 2015.
Which Side Effects has Technivie Been Linked to?
- Liver disease
- Liver failure
- Hepatic decompensation
- Hepatic failure
- Allergic reactions
- Thinning blood
- Difficulty sleeping
Has Technieve Been Recalled?
No recall for Technivie has been issued in the U.S. However, the drug has only been on the market a short time, and it often takes years and many adverse event reports before an allegedly defective drug is recalled.
Which Injuries is Your Law Firm Accepting?
Our lawyers are accepting potential lawsuits on behalf of people who had liver failure or required a liver transplant, or died from liver disease after taking Technivie.
Is There a Class Action?
No class action lawsuit has yet been filed in the Technivie litigation. However, if multiple lawsuits are filed alleging similar injuries, these complaints may be consolidated into a multidistrict litigation (MDL) for pretrial handling. MDLs are different from class actions, and it is generally agreed that consolidating cases instead of proceeding in a class action is a more efficient way of handling claims arising from injuries associated with pharmaceutical products.
Have There Been Any Settlements?
The first Technivie lawsuits have only recently been filed, and the proceedings are still in their early stages. It will likely be several years before AbbVie considers settling some or all of the cases. However, our lawyers feel that the manufacturer will eventually be required to pay substantial settlement amounts as a result of its decision to place profits ahead of safety when failing to warn about the potential health risks of Technivie.